Compare AbCellera Biologics Inc (ABCL) vs Aehr Test Systems (AEHR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Aehr Test Systems — how do they compare? AbCellera Biologics Inc trades at $9.12 (market cap $2.99B), while Aehr Test Systems trades at $119.97 (market cap $3.82B). The key difference: Aehr Test Systems is the larger of the two by market cap, and Aehr Test Systems is trading nearer its 52-week high, AbCellera Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ABCL | AEHR | |
|---|---|---|
Market Cap | $2.99B | $3.82B |
Sector | Health | Technology |
52-Week High | $9.76 | $117.18 |
52-Week Low | $2.78 | $17.38 |
Enterprise Value | $2.58B | $3.72B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Aehr Test Systems
Aehr Test Systems provides testing and burn-in solutions for the semiconductor industry. Its systems ensure the reliability of AI processors, data center chips, and electric vehicle components at the wafer and package levels.
Read more on AEHR →
